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Abstract: Post-exertional malaise (PEM) is regarded as the hallmark symptom in chronic fatigue
syndrome (CFS). The aim of the current study is to explore differences in CFS patients with and
without PEM in indicators of aortic stiffness, autonomic nervous system function, and severity of
fatigue. One-hundred and one patients met the Fukuda criteria. A Chronic Fatigue Questionnaire
(CFQ) and Fatigue Impact Scale (FIS) were used to assess the level of mental and physical fatigue.
Aortic systolic blood pressure (sBPaortic) and the autonomic nervous system were measured with
the arteriograph and Task Force Monitor, respectively. Eighty-two patients suffered prolonged PEM
according to the Fukuda criteria, while 19 did not. Patients with PEM had higher FIS scores (p = 0.02),
lower central systolic blood pressure (p = 0.02) and higher mental fatigue (p = 0.03). For a one-point
increase in the mental fatigue component of the CFQ scale, the risk of PEM increases by 34%. For
an sBPaortic increase of 1 mmHg, the risk of PEM decreases by 5%. For a one unit increase in
sympathovagal balance, the risk of PEM increases by 330%. Higher mental fatigue and sympathetic
activity in rest are related to an increased risk of PEM, while higher central systolic blood pressure is
related to a reduced risk of PEM. However, none of the between group differences were significant
after FDR correction, and therefore conclusions should be treated with caution and replicated in
further studies.
Keywords: PEM; myalgic encephalomyelitis; brain fog; vascular stiffness
1. Introduction
Chronic Fatigue Syndrome (CFS) is characterized by a substantial deterioration of
symptoms that could be provoked in response to physical exercise in patients with post-
exertional malaise (PEM) [1]. The National Academy of Medicine reports the prevalence
of PEM among CFS patients as being from 69 to 100% [2]. PEM is regarded as a hallmark
symptom of CFS [3]. However, some criteria, such as the Fukuda case definition [4], do
not require PEM to be present for a CFS diagnosis. The majority of patients, i.e., 73.4%,
reported the duration of PEM as being equal to or longer than 24 h [5].
The exact mechanism that underlies PEM is as yet unknown. However, it has been
reported that patients with CFS experience shortness of breath [6]. Disruption of the resting
respiratory rate induced by PEM has been observed [7].
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In addition, an attenuated adrenaline response to physical exercise has been observed
in CFS, compared to healthy controls [8], along with more pronounced increases of nitric
oxide metabolites after a physical exercise test [9]. The decreased response of adrenaline
to physical exercise and a disturbance of nitric oxide metabolites are in line with the
observations of Bond et al. [10], who recently proposed that a disturbance in the functioning
of the vascular system was a key factor in PEM pathogenesis.
A decrease in the ability of large arteries to adapt readily to an increase in the amount
of blood ejected during heart muscle contraction has been reported. Aortic pulse wave, or
pulse wave propagation velocity (PWV), and an indirect parameter, the augmentation index
(Aix), constitute a relatively simple, non-invasive, and reproducible method to determine
arterial stiffness [11]. Arterial stiffness has been found to be associated with cardiovascular
events in older cohorts, and, when measured, PWV is considered to be a significant risk
factor for cognitive decline. Furthermore, a less elastic arterial system occurs together with
impaired autoregulation of cerebral perfusion. In consequence, episodes of hypotension
might lead to an increase in the risk of brain hypoperfusion. High arterial stiffness might
occur in CFS patients [12] and could serve as a marker of increased cardiovascular risk
in this population. Słomko et al. show that CFS patients with sympathetic autonomic
dominance had the highest value of arterial stiffness, compared to patients with autonomic
balance [13]. Hunter et al. suggest that a higher elasticity of large arteries was correlated
with lower subjective fatigue in older women with CFS [14].
The Fukuda criteria can distinguish between CFS and chronic fatigue. However,
a further subclassification of the former group into PEM positive and PEM negative
subgroups has been suggested [15]. In contrast to the Fukuda criteria, the Canadian
Consensus Criteria (CCC) require PEM for a diagnosis of CFS [16]. Therefore, it has been
suggested that patients diagnosed on the basis of the Fukuda criteria are a heterogeneous
group [17]. However, unlike generalized fatigue, PEM can be associated with extreme
disruption of daily life functioning [18]. However, the Fukuda definition, which has been
in use for twenty-seven years, has, until recently, been the most widely used case definition
for ME/CFS, and is still very widely used in research and clinical practice. The CCC case
definition identifies a more severely affected subgroup of those patients identified by the
Fukuda definition. The main feature which serves to distinguish those Fukuda-positive
patients who are also CCC-positive from those who are not is the presence of PEM. We
decided to rely on the Fukuda criteria for CFS to examine the differences between the CFS
subgroups of patients with and without PEM. The underlying mechanism of PEM is still not
fully understood; therefore we conducted a cross-sectional study to explore the differences
in selected physiological parameters and symptoms severity in CFS patients with PEM,
compared with those without. The aim of the current study is to examine differences in
CFS patients with and without PEM in indicators of aortic stiffness, autonomic nervous
system function, and severity of physical and mental fatigue.
2. Materials and Methods
The current study took place from January 2013 to July 2018. The Ethics Committee, of
the Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University,
Torun approved the study (KB 332/2013, date of approval: 25 June 2013). Written, informed
consent was obtained from all the participants.
2.1. Enrolment
A group of 131 patients with CFS between 25 and 65 years of age were recruited via
telephone, e-mail, and mass-media advertisements. The main enrolment criteria included:
(1) Fukuda criteria (2) Fatigue Severity Scale score higher than 36 points and persis-
tent fatigue for more than 6 months (3) had suffered from one or more of four additional
symptoms: post-exertional malaise, impaired memory and/or concentration, unrefreshing
sleep, headache, sore throat, tender lymph nodes (axillary or axillary), muscle or joint pain,
(4) perceived fatigue could not be explained by an underlying condition. On inclusion, all
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CFS patients received a pre-test health state assessment: basic neurological, psychiatric,
clinical examination, and had been referred by a general practitioner and by the neurology
and psychiatry departments. The exclusion criteria included: (1) any indication of under-
lying illness, (2) medical condition explaining fatigue, (3) psychiatric disorders. Hospital
Anxiety and Depression Scale (HADS) has been performed to assess anxiety (HADS_A)
and depression (HADS_D) symptoms intensity [19]. Beck Depression Inventory (BDI-II)
was used to examine depression symptoms intensity [20].
30 participants were excluded as they did not meet the Fukuda criteria (n = 10), had
an underlying psychiatric illness (n = 13), or had another diagnosis, or fatigue was not the
primary complain (n = 7).
On the day of investigation all subjects were instructed to eat a light breakfast, and
refrain from smoking, caffeine, alcohol consumption and vigorous physical activity. All
tests were carried out in a chronobiology laboratory (soundproofed room without windows,




The Chalder Fatigue Questionnaire (CFQ) [21], Fatigue Severity Score (FSS) [22]
and the Fatigue Impact Scale (FIS) [23] were administered to provide a comprehensive
assessment of fatigue severity. The CFQ assessed physical and psychological fatigue. It
consists of 11 items that could be divided to mental (4 items) and physical fatigue (7 items)
dimensions. Scoring was made in “Likert” style (in a range from 0 to 3) therefore the total
score could be 0 at minimum and 33 at maximum and from 0 to 12 in mental and from 0 to
21 points in physical dimension. Moreover, binary scoring of the total score (0 for absence
ad 1 for presence) was done. FSS assessed fatigue in the past week. It consists of nine
items that are statements. Patients could choose an option from strongly disagreeing with a
statement (1 point) to strongly agreeing with a particular statement (7 points). Total scores
ranged from 9 to 63 points. FIS assessed cognitive, physical, and psychosocial fatigue.
Higher scores indicate higher severity in all domains. Likert-like scoring with a range of
0–4 points per item was applied to 40 items in total. Therefore the total score could range
from 0 to 160 points. In all fatigue questionnaires, the higher the results in points, the more
severe fatigue.
The Hospital Anxiety and Depression Scale (HADS) was performed to assess anxiety
(HADS_A) and depression (HADS_D) symptoms intensity [19]. The Beck Depression
Inventory (BDI-II) was used to examine depression symptoms intensity [20]. Both scales
were used only at the baseline to exclude patients with depression.
The Epworth sleepiness scale (ESS) [24] was used to assess patients’ general daytime
sleepiness.
2.3. Autonomic Symptom Assessment
We used subjective and objective tools to measure the function of the autonomic
nervous system. The Autonomic Symptom Profile served to measure presence, frequency,
and dynamics of autonomic symptoms severity [25]. Scoring was done based on the
Composite Autonomic Symptom Score 31 (COMPASS 31) [26]. Questionnaire contains 31
items assessing six dimensions of autonomic nervous system function, namely response
to orthostatic stress, vasomotor and secretomotor reactions, function of, bladder and
gastrointestinal tract, as well as pupillomotor reflex. Scores from individual domains were
weighted. The total score is 100 points, the higher the score the higher the symptom load.
In addition, Orthostatic Grading scale (OGS) was used to assess response to orthostatic
stress [27].
Second, ANS functioning was automatically measured with a Task Force Monitor—
TFM (CNS Systems, Gratz, Austria). Signals from a three-channel ECG were analyzed
using the adaptive autoregressive model [28]. Low frequency (LFnu-RRI) (0.04–0.15 Hz)
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and high frequency (HFnu-RRI) (0.15–0.4 Hz) components of R-to-R intervals in normalized
units, as well as its ratio (LF/HR-RRI), were recorded and analyzed in rest. Assessments
were performed after a 5 min waiting period in a supine position, which allowed for signals
to stabilize. Then, an assessment at rest was performed in supine position for a further
5 min.
2.4. Arterial Stiffness
Arterial stiffness was measured using an oscillometric non-invasive Arteriograph
(TensioMed Kft, Budapest, Hungary, www.tensiomed.com, accessed on 18 March 2021).
This is a device that uses a simple upper arm cuff as a sensor, with the cuff pressurized to
at least 35 mmHg over the actual systolic pressure. The device determines the PWVaortic
and augmentation index according to the manufacturer’s instructions. Arteriograph mea-
surement has been described extensively in previous papers [29–31]. The Arteriograph,
simultaneously with the arterial stiffness parameters, also records the actual systolic and
diastolic blood pressure (BPs) and heart rate.
The difference between the central and peripheral systolic blood pressure was calcu-
lated based on measurement from arteriography and TFM, respectively.
2.5. Statistical Analysis
Histogram visual inspection and the Shapiro–Wilk test were applied to test the nor-
mality assumption. To examine between-group differences (patients with PEM vs. those
without) Mann–Whitney U or independent T-tests were used, depending on assumptions
met. To predict presence of PEM in examined patients, a logistic regression model using the
GLM function was applied in R. In addition, 95% confidence intervals for log-likelihoods
and odds ratios were calculated (confit function using bootstrap). The DescTools pack-
age was used to calculate pseudo R2 for the model [32]. Dotwhisker plots were used
to visualize odds ratios and confidence intervals [33]. Violin graphs were created us-
ing R [34] with a ggstatsplot library [35]. Effect sizes from the ggstatsplot library are
reported for between group comparisons. The false discovery rate (FDR) was controlled
using a Benjamini–Hochberg adjusted p-value, applying an online calculator available
at (https://tools.carbocation.com/FDR, accessed on 18 March 2021). The results contain
p-values before as well as after correction.
3. Results
One hundred and one patients met the Fukuda criteria for CFS and were included
in the analysis (Table 1). The patients were divided into groups with PEM or without
PEM. Eighty-two patients reported prolonged PEM, whilst nineteen patients were free of
prolonged PEM. Both groups consisted predominantly of women, comprising fifty-one
patients from PEM group (62.2%), and fourteen (73.7%) in the group without PEM. Table 1
describes detailed characteristics about the total group and group differences between the
patients with PEM and those without.
Table 2 presents differences in arteriography results between patients with PEM and
those without PEM. Table 3 indicates differences between patients with PEM and those
without PEM, in respect of autonomic nervous system function indicators.
Patients with PEM had higher overall fatigue, as measured by FIS (81.61 ± 30.3 vs.
63.05 ± 33.9, t = −2.19, p = 0.02, Hedges’ g = −0.57 (−1.07, −0.03), and higher mental
fatigue (9.13 ± 1.8 vs. 7.95 ± 2.2, Z = 2.18, p = 0.03, r = −0.22 (−0.39, −0.03) (Table 1). Mean
fatigue scores in the total sample were 23.68 points (range 0–33 points) in the CFQ scale,
47.03 points (range 9–63 points) in FSS, and 78.12 points (range 0–160 points) in FIS.
BMI—body mass index, CFQ—Chalder Fatigue Questionnaire, FSS—Fatigue Severity
Scale, FIS—Fatigue Impact Scale, HADS_A—Hospital Anxiety and Depression Scale anxi-
ety, HADS_D—Hospital Anxiety and Depression Scale depression; BDI—Beck Depression
Inventory, ESS—Epworth Sleepiness Scale, OGS—Orthostatic Grading Scale, Compass-31—
Composite Autonomic Symptom Score 31.
J. Clin. Med. 2021, 10, 2327 5 of 12
Patients with PEM had lower central systolic blood pressure than those without PEM
(127.49 ± 15 vs. 141.05 ± 21.1, Z = −2.37, p = 0.02, r = 0.24 (0.06, 0.44) (Table 2). No
significant differences in blood pressure measured peripherally were observed (Table 2).
PWVaortic—Pulse Wave Velocity aortic, sBPaortic—aortic systolic blood pressure,
central-peripheral sBP—difference between central and peripheral systolic blood pressure
levels.
Patients with PEM had higher LFnu-RRI (56.61 ± 16.7 vs. 46.64 ± 13.9, Z = 2.58, p =
0.01, r = −0.26 (−0.45, −0.06), lower HFnu-RRI (43.39 ± 16.7 vs. 53.36 ± 13.9, Z = -2.58, p =
0.01, r = 0.26 (0.07, 0.44) and higher LF/HF-RRI (1.96 ± 2.2vs. 1.13 ± 0.9, Z = 2.37, p = 0.02,
r = −0.24 (−0.42, −0.06). Also, LF/HF was higher in patients with PEM (1.66 ± 1.5 vs. 0.94
± 0.5, Z = 2.96, p = 0.003, r = −0.29, (−0.45, −0.14). In addition, patients with PEM had
higher LFnu-dBP (53.88 ± 14.4 vs. 43.45 ± 13.8, Z = 2.69, p = 0.01, r = −0.27 (−0.47, −0.11)
and higher LF/HF-dBP (7.27 ± 6.0 vs. 4.32 ± 3.6, Z = 2.36, p = 0.02, r = −0.23, (−0.45,
−0.04) (Table 3).
Table 1. Demographic data of total examined sample (n = 101) and comparison of demographic data and questionnaires
results of patients with PEM and without PEM, respectively.
Variable TotalSample PEM Mean ± SD Without PEM Mean ± SD p-Value FDR p-Value
Age [years] 38.15 ± 8.0 38.23 ± 8.1 37.79 ± 8.0 0.83 0.88
Height [cm] 171.55 ± 8.4 172.07 ± 8.7 169.32 ± 6.6 0.20 0.15
Weight [kg] 72.22 ± 12.6 72.77 ± 12.6 69.84 ± 12.5 0.36 0.61
BMI 24.47 ± 3.6 24.51 ± 3.5 24.31 ± 3.8 0.83 0.85
Symptoms duration [years] 4.54 ± 4.1 4.75 ± 4.2 3.64 ± 3.7 0.20 0.44
CFQ [points] 23.68 ± 4.6 24.07 ± 4.6 22.00 ± 4.4 0.08 0.21
CFQ_BINARY [points] 14.06 ± 4.8 14.49 ± 4.6 12.21 ± 5.1 0.07 0.22
CFQ_PHYSICAL [points] 10.47 ± 3.9 10.39 ± 4.0 10.79 ± 3.7 0.50 0.69
CFQ_MENTAL [points] 8.91 ± 2.0 9.13 ± 1.8 7.95 ± 2.2 0.03 0.11
FSS [points] 47.03 ± 10.1 47.57 ± 9.4 44.68 ± 12.8 0.46 0.68
FIS [points] 78.12 ± 31.6 81.61 ± 30.3 63.05 ± 33.9 0.02 0.09
HADS_A [points] 9.27 ± 3.5 9.22 ± 3.4 9.47 ± 4.2 0.78 0.87
HADS_D [points] 7.85 ± 3.4 8.00 ± 3.5 7.21 ± 2.9 0.36 0.63
BDI [points] 15.83 ± 7.9 16.15 ± 8.1 14.39 ± 6.9 0.57 0.75
ESS [points] 10.86 ± 5.6 11.01 ± 5.5 10.21 ± 6.3 0.65 0.78
OGS [points] 3.64 ± 3.2 3.71 ± 3.4 3.37 ± 2.5 0.98 0.98
Orthostatic intolerance
[points] 11.96 ± 11.0 12.24 ± 11.3 10.74 ± 10.0 0.67 0.77
Vasomotor [points] 0.83 ± 1.4 0.86 ± 1.4 0.70 ± 1.4 0.57 0.73
Secretomotor [points] 5.52 ± 3.9 5.64 ± 3.9 4.96 ± 3.9 0.49 0.70
Gastrointestinal [points] 5.09 ± 4.2 4.89 ± 4.1 5.97 ± 4.7 0.37 0.60
Bladder [points] 0.54 ± 0.9 0.57 ± 1.0 0.41 ± 0.8 0.60 0.74
Pupillomotor [points] 1.15 ± 1.2 1.22 ± 1.2 0.86 ± 0.9 0.38 0.59
Compass-31 Total [points] 25.09 ± 14.7 25.43 ± 15.0 23.64 ± 13.4 0.81 0.88
Table 2. Comparison of arteriography results of patients with PEM and without PEM.
Variable PEM Mean ± SD Without PEM Mean ± SD p-Value FDR p-Value
PWVaortic [m/s] 8.33 ± 1.7 8.65 ± 1.8 0.21 0.41
Aixaortic [%] 28.11 ± 14.4 32.95 ± 15.5 0.20 0.41
sBPaortic [mmHg] 127.49 ± 15 141.05 ± 21.1 0.02 0.12
central-peripheral sBP [mmHg] 9.56 ± 21.7 23.41 ± 25.7 0.06 0.20
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Table 3. Comparison of autonomic parameters in patients with PEM and without PEM.
Variable PEM Mean ±SD
Without PEM
Mean ± SD p-Value FDR p-Value
Spectral analysis of HR variability
LFnu-RRI 56.61 ± 16.7 46.64 ± 13.9 0.01 0.12
HFnu-RRI 43.39 ± 16.7 53.36 ± 13.9 0.01 0.19
LF/HF-RRI 1.96 ± 2.2 1.13 ± 0.9 0.02 0.08
LF/HF 1.66 ± 1.5 0.94 ± 0.5 0.003 0.11
Spectral analysis of BP variability
LFnu-dBP 53.88 ± 14.4 43.45 ± 13.8 0.01 0.09
HFnu-dBP 11.67 ± 7.3 18.20 ± 16.0 0.07 0.20
LF/HF-dBP 7.27 ± 6.0 4.32 ± 3.6 0.02 0.11
LFnu-sBP 42.86 ± 14.0 38.14 ± 13.7 0.19 0.44
HFnu-sBP 14.86 ± 9.3 18.74 ± 14.0 0.31 0.57
LF/HF-sBP 4.10 ± 2.8 3.02 ± 1.8 0.17 0.42
LFnu—low frequency normalized units, HFnu—high frequency normalized units,
LF/HF—ratio of low frequency to high frequency, RRR—R to R interval, sBP—systolic
blood pressure, dBP—diastolic blood pressure.
Figure 1 presents differences between patients without PEM and patients with PEM
in the level of the CFQ mental fatigue sub-score (Figure 1a), aortic sBP (Figure 1b) and
sympathovagal balance (Figure 1c). This set of variables was then included in logistic
regression models as PEM presence predictors.
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Figure 2 shows the estimate of parameters and their confidence interval (−95%, 95%)
in logistic regression analysis. In terms of odds ratios, the results were as follows: for a
one point more increase in the mental fatigue component of the CFQ scale, the risk of
PEM increases by 34% (CI = 2%, 80%). For an aortic systolic blood pressure increase of
1 mmHg, the risk of PEM decreases by 5% (CI = 9%, 2%). For a one unit more increase
in sympathovagal balance, the risk of PEM increases by 330% (CI = 50%, 1516%). (AIC =
81.18, BIC = 91.6, Tjur’s R2 = 0.26) (Table A1 in Appendix A).
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4. Discussion
The results of the present study have shown that CFS patients with PEM had sig-
nificantly higher mental fatigue, overall fatigue being measured by FIS, which was one
of the three fatigue scales used in the above research. Moreover, patients with PEM had
lower central systolic blood pressure. However, no difference in levels of peripheral blood
pressure was observed. Higher mental fatigue is related to a higher risk of PEM, while
higher central systolic blood pressure is related to lower risk of PEM. However, none of the
between gr up difference were significant after FDR correction, and therefore conclusions
shoul be treat d ith caution a d replicated in further stu ies.
As has been noted in the introduct on, 73.4% assessed PEM duration as equal to
or long r than 24 h [5]. As a result of the dramatic ecline in patients’ physical and/or
cognitive functioning, some p ents might have to adjust their lifestyle a d activity levels
to avoid inducing PEM [2]. Some 25–29% of pa ients are reported to be bedbound or
housebound [2]. The annual cost of CFS in the USA is estimate t be around $18 to $24
billion [2]. PEM was proposed a a prognos ic indicator of CFS course [2], so studies of
PEM have high clinical sig ifi nce. Exploration of the PEM mechanism could lead to more
effective thera eutic approaches, and thus to improvement f overall patient function.
The above findings are in line with previous research, which suggests that chronic vas-
cular damage might cause a lack of exercise-induced vasodilation and be a potential cause
of PEM [10]. In CFS, reduced blood pressure is frequently reported [36,37]. Additionally, an
inverse relationship between increasing fatigue and diurnal blood pressure variation has
been observed [38]. In our sample, despite a lack of difference in peripheral systolic blood
pressure (with a mean lower than 120 mmHg in both groups), increased central systolic
blood pressure was observed in patients with PEM. In certain conditions, such as during
physical activity, the correlation between peripheral and central systolic blood pressure
may decrease [38]. It is tempting to speculate that an increase in central systolic blood
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pressure in some CFS patients might occur before other pathological changes. Conversely,
increased arterial stiffness was observed in healthy young adults in response to acute sleep
deprivation. Arterial stiffness might therefore be secondary to comorbidities, such as sleep
disturbance [39]. Further studies should examine the exact mechanism underlying the
relationship between central systolic blood pressure, PEM fatigue, and factors responsible
for blood pressure regulation in CFS. As a result of the rich symptomatology, an attempt
should be made to classify different subgroups of CFS patients according to comorbidities.
Further studies could possibly focus on the vascular system in all CFS patients, or perhaps
just in a specific sub-group. Further exploration of this field would be helpful to establish
possible personalized therapeutic approaches in CFS. In the present study, PEM presence
was related to a higher mental fatigue component. Moreover, our previous study has
shown that arterial stiffness parameters are related to fatigue severity; higher FIS and lower
FSS scores were related to lower aortic stiffness [13]. Presumably, some of the mechanisms
underlying this relationship could similarly link central blood pressure to PEM. Thus,
mental fatigue might be related to dysfunction in ß2 adrenergic receptor and vascular or
endothelial function, which in turn could lead to reduced cerebral blood flow (CBF) [40].
A decrease in CBF has been observed in CFS patients [41] and CBF has been shown to be
correlated with fatigue severity [42]. Significantly, a negative correlation was seen between
CBF and skeletal muscle pH at rest, which might explain why mental fatigue could be
related to muscular fatigue [43]. However, the mechanisms described above are purely
speculative and need to be examined in further studies.
In the current study, sympathetic nervous system function was more active during
rest in the group with PEM, compared with the group without PEM. Moreover, indicators
of parasympathetic nervous system activity were lower during rest. Findings in the
PEM group are in line with the previous study by Frith et al. [36], where LF-dBP at rest
was higher in a CFS group compared to controls. Parasympathetic activity was reduced
in the CFS patients after inducing PEM [44]. During physical exercise, cardiac output
distribution is governed by the sympathetic nervous system [45]. Surprisingly, in the PEM
group, increased sympathetic drive coexisted with lower central systolic blood pressure.
It is noteworthy that numerous factors can have an impact on the control of the ANS in
the constriction of vascular beds, individual vessels, and even different parts of the same
vessel [45]. Those factors include density and subtypes of adrenergic receptors and action of
contransmitters, norepinephrine kinetics, density of sympathetic innervations, and degree
of basal tone [45]. Additionally, local factors, such as the concentrations of vasoactive tissue
metabolites, vessel size, and structure may also play a part in changes in vessel diameter
and therefore in cardiac output distribution [45]. The disturbance in some of those factors
could play an important role in PEM pathogenesis. Similar mechanisms for PEM have
been proposed [40]. However, based on our findings, it is not possible to delineate the
exact mechanism underlying the observed disturbances in ANS and whether it is related to
PEM. Further studies should examine vascular function in response to stressors and its role
in PEM. Understanding PEM mechanisms could contribute to the development of specific
PEM therapy.
What is surprising is that the current results, corrected for multiple comparisons,
showed no significant differences between the subgroup with PEM and that without PEM,
in terms of fatigue as measured by scales. This is in contrast to a previous study, where
higher PEM intensity was related to higher frequency and intensity of symptoms, and
greater problems with emotional regulation [17]. However, discrepancies in the results
observed might be related to a difference in methodology. In the current study, the division
of CFS patients into PEM present or PEM absent subgroups was based on a binary variables
(presence of prolonged post-exertional malaise), while May et al. divided patients into a
group with no to moderate intensity of PEM (loPEM), and a group with severe to very
severe PEM (hiPEM) [17]. Future studies should further examine if PEM is a distinct
characteristic feature, on which basis a subgroup of CFS patients might be distinguished, or
whether PEM is related directionally or non-directionally to other symptoms from which
J. Clin. Med. 2021, 10, 2327 9 of 12
CFS patients suffer. In addition, it was suggested that further multi-center studies on CFS
should apply the same protocols [46]. Therefore, it is necessary to make a decision as to
whether PEM should be a symptom required for CFS diagnosis, which would have an
impact on the types of criteria of CFS used in research.
Study Limitations
In the above study, PEM was measured subjectively. Further studies should incorpo-
rate a protocol based on repeated Cardiopulmonary Exercise Tests, to confirm objectively
the presence of PEM in CFS patients. A difference in sample size between the subgroup
with PEM and that without PEM was observed, which seems to reflect PEM prevalence
in the general population. By increasing the sample size, a higher number of patients
without PEM could be included as a control group. Sample size should therefore be in-
creased in further studies on PEM in CFS. Meta-analysis showed that PEM occurs 10.4
times more frequently in CFS patients in comparison with other groups [47]. Comparison
between patients with CFS might potentially reduce potentially confounding factors. The
present study design is cross sectional, so no conclusions about causality can be drawn
based on the current results. Further studies should explore the PEM mechanism applying
intervention-based protocols. In addition, to reveal potential biological mechanisms, a
deep phenotyping approach could be chosen, using a repeated CPET protocol to elicit PEM
and to examine changes in biomarkers related to changes in PEM.
5. Conclusions
Patients with PEM had significantly higher mental fatigue and overall fatigue than
those without PEM, as measured by FIS, one of the three fatigue scales used in the above
research. They also had higher mental fatigue and sympathetic activity compared with
parasympathetic activity during rest and lower central systolic blood pressure. However,
none of these differences remained statistically significant after correction for multiple
comparisons. Further studies should be conducted to confirm if higher mental fatigue and
higher sympathetic activity, compared with parasympathetic activity at rest and lower
central systolic blood pressure, are related to a higher risk of PEM.
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